Watch live as Trump attends a House Republican retreat as he presses his agenda on immigration, tariffs and DEI through ...

Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...

Metsera Inc. is seeking to raise $292 million in an initial public offering, joining a clutch of health-care firms set to ...

Discover the top-performing biotech stocks in 2024! From oncology to psychedelics some companies showed remarkable results.

Costly biomanufacturing sterilization process are impeding food-tech companies from scaling up — a problem Biosphere is ...

Most San Francisco employers must spend a minimum amount on health care for employees who work 8 or more hours per week. Top-offs for 2024 Self-Funded Health Plans are due February 28th, 2025.

Twelve Northwestern students attended the annual Conference of the Parties to the UN Framework Convention on Climate Change, COP29, to conduct research. The delegation presented their findings at a ...

Press Release ImmunoMet Therapeutics, Inc., ("ImmunoMet", or the "Company"), a clinical stage biotechnology company committed to giving patients a novel approach to fight cancer, today provided a data ...

HighlightsTopline data for ATH434-201 randomized, double-blind Phase 2 clinical trial on track for expected release by early February ...

Results from GALILEO-1, a first in human clinical trial of FLT201 AAV-gene therapy in adult patients with Gaucher disease type 1 (Poster #318) Session: Poster Session III Date & Time: Thursday, ...

Pharma dealmaking for drugs invented in China is putting pressure on U.S. biotechs to compete harder, according to investors ...